Description

Pyrazino[2,1-C][1,2,4]Thiadiazine, 9-[4-(Cyclohexyloxy)Phenyl]-3,4-Dihydro-7-Methyl-, 2,2-Dioxide is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value for research and development in medicinal chemistry, particularly for its potential role as a key building block in novel active pharmaceutical ingredients (APIs). It is primarily needed by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers focused on developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of novel drug candidates, particularly in therapeutic areas targeting central nervous system (CNS) disorders or inflammatory diseases.
• Medicinal Chemistry Research: Used as a scaffold or building block for structure-activity relationship (SAR) studies to optimize biological activity and pharmacokinetic properties.
• Process Chemistry Development: Employed in route scouting and optimization for the scalable synthesis of target molecules in pre-clinical and early clinical development phases.
• Reference Standard: Supplied as a high-purity compound for analytical method development, validation, and quality control testing in API manufacturing.
• Biochemical Research: Potential use as a tool compound for investigating specific enzymatic pathways or biological targets in vitro.

Basic Information

Product Name	Pyrazino[2,1-C][1,2,4]Thiadiazine, 9-[4-(Cyclohexyloxy)Phenyl]-3,4-Dihydro-7-Methyl-, 2,2-Dioxide
CAS No.	1358751-06-0
Molecular Formula	C20H23N3O3S
Molecular Weight	385.48 g/mol
Synonyms	9-[4-(Cyclohexyloxy)phenyl]-3,4-dihydro-7-methylpyrazino[2,1-c][1,2,4]thiadiazine 2,2-dioxide; 7-Methyl-9-[4-(cyclohexyloxy)phenyl]-3,4-dihydro-2H,6H-pyrazino[2,1-c][1,2,4]thiadiazine 2,2-dioxide; CAS 1358751-06-0; Pyrazinothiadiazine dioxide derivative; Advanced pharmaceutical intermediate 1358751-06-0.
EINECS	Contact for details

Quality Control

Our Pyrazino[2,1-C][1,2,4]Thiadiazine derivative is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and residual solvent analysis, to ensure it meets the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) with full traceability are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). For long-term storage, consider storing under an inert atmosphere to ensure maximum stability. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Meets ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.